Jason Careri
Psychiatry · Garden City, NYNPI 1184853533
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (57.1%), speaking fees and education — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Johnson & Johnson at 44.0% of the total. Reporting peaked in 2020 at $4,401 and has fallen 61.0% since, to $1,715 in 2025. Among psychiatry clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 299 payments — averaging $33.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$4K
- AbbVie$2K
- Takeda Pharmaceuticals U.S.A., Inc.$896
- Otsuka America Pharmaceutical, Inc.$892
- Lundbeck LLC$872
- Vanda Pharmaceuticals Inc.$504
- plus $828 from 7 others
Across 181 payments — averaging $7485.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Axsome Therapeutics, Inc.$505K
- Janssen Research & Development, LLC$427K
- Sumitomo Pharma America, Inc.$409K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$12K
- Supernus Pharmaceuticals, Inc.$2K
What the payments were for
- Speaking & faculty fees$4,20042%
- Food & beverage$5,67857%
- Education$611%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 14 | $4,377 |
| AbbVie(2 entities) | 77 | $1,569 |
| Takeda Pharmaceuticals U.S.A., Inc. | 50 | $896 |
| Otsuka America Pharmaceutical, Inc. | 41 | $892 |
| Lundbeck LLC | 52 | $872 |
| Vanda Pharmaceuticals Inc. | 19 | $504 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 28 | $413 |
| Almatica Pharma LLC | 9 | $184 |
| E.r. Squibb & Sons, L.L.C. | 3 | $120 |
| Shire North American Group Inc | 3 | $52 |
| Biogen | 1 | $24 |
| Alkermes, Inc. | 1 | $22 |
| Avanir Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,940 in reported general payments places this provider in the 90th percentile of 3,713 psychiatry providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrintellixVortioxetine Hydrobromide | 13 | $13,491 |
| Duloxetine Hcl | 20 | $1,369 |
| Ziprasidone Hcl | 15 | $555 |
| Mirtazapine | 19 | $411 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 16 | $363 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 16 | $311 |
| Clonazepam | 47 | $295 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 11 | $295 |
| Bupropion XlBupropion Hcl | 28 | $267 |
| Sertraline Hcl | 23 | $234 |
| Escitalopram Oxalate | 17 | $228 |
| Aripiprazole | 12 | $186 |
| Prazosin Hcl | 18 | $145 |
| Buspirone Hcl | 11 | $134 |
| Lamotrigine | 26 | $86 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $896 | $13,49113 claims |
| Almatica Pharma LLCSertraline Hcl | $184 | $23423 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,713 psychiatry providers in New York.
Other psychiatry in Garden City
- Leslie CitromePomona$5.7M
- Sanjay GuptaCheektowaga$1.9M
- Richard PriceMonsey$1.7M
- Adam AshtonAmherst$1.6M
- Christoph CorrellGlen Oaks$1.5M
- Manish ZinzuvadiaNew York$1.3M
- George KruseBronx$1.2M
- Jianping ChenNew York$1.2M
- Horacio CapoteAmherst$1.1M
- Yadagiri ChepuruYonkers$963K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.